Log In
Print
BCIQ
Print
Print this Print this
 

DX-2930

  Manage Alerts
Collapse Summary General Information
Company Dyax Corp.
DescriptionHuman mAb against plasma kallikrein
Molecular Target Kallikrein
Mechanism of Action 
Latest Stage of DevelopmentPreclinical
IndicationAngioedema
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today